Page 1

Ref : Syn / CS / SE / BM / 2021-22 / Apr / 14 Syngene Syngene International Limited Biocon SEZ , Biocon Park , Plot No. 2 & 3 , Bommasandra Industrial Area , IV Phase , Jigani Link Road , Bengaluru 560 099 , Karnataka , India T +91 80 6891 8000 F +91 80 6891 8808 CIN : L85110KA1993PLC014937 www.syngeneintl.com April 27 , 2021 To , The Manager , BSE Limited Corporate Relationship Department Dalal Street , Mumbai - 400 001 Scrip Code : 539268 To , The Manager , National Stock Exchange of India Limited Corporate Communication Department Bandra ( EAST ) , Mumbai - 400 051 Scrip Symbol : SYNGENE Sub : Outcome of the Board Meeting Dear Sir / Madam , Pursuant to Regulation 30 and 33 of SEBI ( Listing Obligations and Disclosure Requirements ) , Regulations 2015 , we wish to inform you that the Board of Directors at its meeting held today , has considered the following : Approved Audited financial results ( consolidated and standalone ) as per Indian Accounting Standard ( Ind - AS ) for the quarter and year ended March 31 , 2021. A copy of the audited financial results along with the Auditors ' Report and a declaration under Regulation 33 ( 3 ) ( d ) of SEBI ( LODR ) Regulations , 2015 is enclosed herewith . Recommended re - appointment of M / s . B S R & Co LLP as statutory auditors of the Company for a second term of five years , which is subject to approval of the shareholders of the Company at the ensuing 28th Annual General Meeting . • Approved convening of 28th Annual General Meeting of the Company on Wednesday , July 21 ,